Cel
To contribute to the development of vaccines against Shigella and ETEC for children of the developing world, STOPENTERICS will provide novel solutions by imposing a two-fold paradigm switch: (i) to break the dogma of serotype-specificity by inducing a cross-protective immunity (ii) to improve the immunogenicity of Shigella glycoconjugates by using synthetic oligosacharides mimicking the lipopolysaccharide O-antigen. The possibilities offered by genomics/proteomics and bacterial outer membrane blebs (OMB) will be exploited to identify virulence proteins conserved throughout Shigella or ETEC isolates. For ETEC, the development of a safe, immunogenic ST (heat stable) toxoid is a priority. State-of-the-art glycochemistry and sugar-protein carrier conjugation will allow engineering optimal Shigella glycoconjugates with focus on the five most prevalent serotypes. The ultimate aim is to optimize chances for the best coverage by combining cross-protective and serotype-specific antigens, thus ensuring the development of efficient multivalent vaccines that will help reduce the burden of diarrheal diseases. At all stages of the R & D process, candidate antigens will be considered in light of immunomonitoring data obtained in naturally-infected individuals, and volunteers undergoing vaccine trials. Regarding the latter, Phase-1 clinical trials with two vaccine candidates are planned as proofs–of-concept of (i) a synthetic oligosaccharides approach mimicking Shigella O-antigens, and (ii) a Shigella OMB-based vaccines to be tested after validation of preclinical studies. STOPENTERICS is a unique combination of laboratories, platforms, vaccinology centres from academia and industry in the North and the South, integrated to successfully develop new vaccines, from R&D toward clinical trials. By promoting high-standard training capacity for young investigators, it will foster a new generation of researchers in neglected infectious diseases.
Dziedzina nauki
Zaproszenie do składania wniosków
FP7-HEALTH-2010-single-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP-SICA - Large-scale integrating project for specific cooperation actions dedicated to international cooperation partner countries(SICA)Koordynator
75724 Paris
Francja
Zobacz na mapie
Uczestnicy (17)
5020 Bergen
Zobacz na mapie
Zakończenie uczestnictwa
SW7 2AZ LONDON
Zobacz na mapie
1050 Bruxelles / Brussel
Zobacz na mapie
00185 Roma
Zobacz na mapie
405 30 Goeteborg
Zobacz na mapie
1212 Dhaka
Zobacz na mapie
69978 Tel Aviv
Zobacz na mapie
69007 Lyon
Zobacz na mapie
53100 Siena
Zobacz na mapie
75012 Paris
Zobacz na mapie
N/A LEGON ACCRA
Zobacz na mapie
CB10 1SA SAFFRON WALDEN
Zobacz na mapie
1002 Lausanne
Zobacz na mapie
Zakończenie uczestnictwa
3721 MA Bilthoven
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie
2500 EJ Den Haag
Zobacz na mapie
64239 Tel Aviv
Zobacz na mapie